| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
35,720,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$ - $ |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile HCW Biologics is a biopharmaceutical company focused on discovering and developing immunotherapies to lengthen health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. Co. has selected two molecules as its primary product candidates: HCW9218 and HCW9302. HCW9218 is designed to treat the impact of accumulated senescent cells and the Senescence-Associated Secretory Phenotype (SASP) factors which they secrete by eliminating senescent cells and reducing SASP factors. HCW9302 is designed to activate and expand regulatory T cells to suppress the activity of inflammasome-bearing cells and the inflammatory factors which they secrete.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
129,008 |
505,416 |
| Total Buy Value |
$0 |
$0 |
$253,088 |
$1,101,173 |
| Total People Bought |
0 |
0 |
4 |
5 |
| Total Buy Transactions |
0 |
0 |
21 |
53 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Flowers Lee |
SVP of Business Development |
• – – |
2023-06-08 |
4 |
B |
$2.16 |
$21,574 |
D/D |
10,000 |
111,308 |
2.74 |
- |
|
| Flowers Lee |
SVP of Business Development |
• – – |
2023-06-08 |
4 |
OE |
$0.14 |
$750 |
D/D |
5,356 |
101,308 |
|
- |
|
| Byam Rebecca |
Chief Financial Officer |
• – – |
2023-06-08 |
4 |
B |
$2.21 |
$10,388 |
D/D |
4,696 |
523,946 |
2.74 |
- |
|
| Byam Rebecca |
Chief Financial Officer |
• – – |
2023-06-07 |
4 |
B |
$2.03 |
$40,632 |
D/D |
20,000 |
519,250 |
2.74 |
- |
|
| Byam Rebecca |
Chief Financial Officer |
• – – |
2023-06-06 |
4 |
B |
$1.82 |
$34,779 |
D/D |
19,062 |
499,250 |
2.74 |
- |
|
| Byam Rebecca |
Chief Financial Officer |
• – – |
2023-06-05 |
4 |
B |
$1.67 |
$33,344 |
D/D |
20,000 |
480,188 |
2.74 |
- |
|
| Wong Hing C |
Chief Executive Officer |
• • – |
2023-06-02 |
4 |
B |
$1.54 |
$1,228 |
D/D |
800 |
15,313,068 |
2.73 |
- |
|
| Wong Hing C |
Chief Executive Officer |
• • – |
2023-06-01 |
4 |
B |
$1.62 |
$1,294 |
D/D |
800 |
15,312,268 |
2.73 |
- |
|
| Winer Gary M |
Director |
– • – |
2023-05-31 |
4 |
B |
$1.50 |
$750 |
D/D |
500 |
14,350 |
2.31 |
- |
|
| Wong Hing C |
Chief Executive Officer |
• • – |
2023-05-31 |
4 |
B |
$1.55 |
$3,092 |
D/D |
2,000 |
15,311,468 |
2.73 |
- |
|
| Winer Gary M |
Director |
– • – |
2023-05-30 |
4 |
B |
$1.52 |
$1,293 |
D/D |
850 |
13,850 |
2.31 |
- |
|
| Wong Hing C |
Chief Executive Officer |
• • – |
2023-05-30 |
4 |
B |
$1.55 |
$4,658 |
D/D |
3,000 |
15,309,468 |
2.73 |
- |
|
| Byam Rebecca |
Chief Financial Officer |
• – – |
2023-05-26 |
4 |
B |
$1.66 |
$33,196 |
D/D |
20,000 |
460,188 |
2.74 |
- |
|
| Byam Rebecca |
Chief Financial Officer |
• – – |
2023-05-25 |
4 |
B |
$1.62 |
$32,348 |
D/D |
20,000 |
440,188 |
2.74 |
- |
|
| Byam Rebecca |
Chief Financial Officer |
• – – |
2023-05-24 |
4 |
B |
$1.61 |
$32,150 |
D/D |
20,000 |
420,188 |
2.74 |
- |
|
| Byam Rebecca |
Chief Financial Officer |
• – – |
2023-05-23 |
4 |
B |
$1.57 |
$7,887 |
D/D |
5,036 |
400,188 |
2.74 |
- |
|
| Byam Rebecca |
Chief Financial Officer |
• – – |
2023-05-22 |
4 |
B |
$1.53 |
$51,045 |
D/D |
33,450 |
395,152 |
2.74 |
- |
|
| Byam Rebecca |
Chief Financial Officer |
• – – |
2022-11-02 |
4 |
OE |
$0.14 |
$4,725 |
D/D |
33,750 |
361,702 |
|
- |
|
| Byam Rebecca |
Chief Financial Officer |
• – – |
2022-09-14 |
4 |
B |
$2.58 |
$38,651 |
D/D |
15,000 |
327,952 |
2.74 |
- |
|
| Byam Rebecca |
Chief Financial Officer |
• – – |
2022-09-13 |
4 |
B |
$2.58 |
$38,651 |
D/D |
15,000 |
312,952 |
2.74 |
- |
|
| Byam Rebecca |
Chief Financial Officer |
• – – |
2022-09-12 |
4 |
B |
$2.65 |
$39,764 |
D/D |
15,000 |
297,952 |
2.74 |
- |
|
| Wong Hing C |
Chief Executive Officer |
• • – |
2022-09-09 |
4 |
B |
$2.70 |
$16,200 |
D/D |
6,000 |
15,306,468 |
2.81 |
- |
|
| Wong Hing C |
Chief Executive Officer |
• • – |
2022-09-08 |
4 |
B |
$2.67 |
$10,680 |
D/D |
4,000 |
15,300,468 |
2.81 |
- |
|
| Wong Hing C |
Chief Executive Officer |
• • – |
2022-09-07 |
4 |
B |
$2.58 |
$15,480 |
D/D |
6,000 |
15,296,468 |
2.81 |
- |
|
| Wong Hing C |
Chief Executive Officer |
• • – |
2022-09-02 |
4 |
B |
$2.55 |
$10,200 |
D/D |
4,000 |
15,290,468 |
2.81 |
- |
|
91 Records found
|
|
Page 2 of 4 |
|
|
